Loading...
XSHE000950
Market cap1.21bUSD
Jan 14, Last price  
5.12CNY
1D
2.40%
1Q
-2.29%
Jan 2017
-45.36%
Name

C.Q. Pharmaceutical Holding Co Ltd

Chart & Performance

D1W1MN
XSHE:000950 chart
P/E
13.51
P/S
0.11
EPS
0.38
Div Yield, %
14.68%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
25.43%
Revenues
80.12b
+18.12%
288,432,848333,039,287973,958,0941,023,041,9221,449,450,3222,083,651,1872,078,260,0622,588,551,1863,322,656,5193,437,228,4492,968,713,2813,326,469,7482,567,050,72423,044,600,74825,802,739,16033,843,821,48045,219,570,78662,520,755,30267,829,010,43880,119,107,344
Net income
655m
-31.22%
7,965,291082,322,079145,444,648272,746,680204,659,903132,338,95790,891,359121,371,2957,277,8340001,106,266,191690,667,278788,015,791884,344,2171,005,444,242952,275,637654,956,871
CFO
509m
+77.92%
58,297,50090,148,531297,730,23800247,738,65310,978,624159,877,668349,298,218402,367,2005,738,571190,114,550247,546,08200202,411,337631,986,342250,164,875285,828,791508,534,274
Dividend
Jun 06, 20240.05 CNY/sh
Earnings
May 16, 2025

Profile

C.Q. Pharmaceutical Holding Co., Ltd. distributes pharmaceutical products. Chongqing Medicines Co., Ltd. was formerly known as Southwest Branch of China Medicine Company. The company was founded in 1950 and is based in Chongqing, China. C.Q. Pharmaceutical Holding Co., Ltd. develops, manufactures, and distributes pharmaceuticals. The company is based in Chongqing, China. C.Q. Pharmaceutical Holding Co., Ltd. operates as a subsidiary of Chongqing Chemical & Pharmaceutical Holding Group Company
URL
https://www.cqphar.com/cqp/
IPO date
Sep 16, 1999
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
80,119,107
18.12%
67,829,010
8.49%
Cost of revenue
75,100,437
64,356,301
Unusual Expense (Income)
NOPBT
5,018,670
3,472,710
NOPBT Margin
6.26%
5.12%
Operating Taxes
236,042
309,496
Tax Rate
4.70%
8.91%
NOPAT
4,782,629
3,163,214
Net income
654,957
-31.22%
952,276
-5.29%
Dividends
(1,299,015)
(112,408)
Dividend yield
15.16%
1.28%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
18,473,485
18,789,656
Long-term debt
4,878,932
3,556,031
Deferred revenue
68,024
73,084
Other long-term liabilities
420,443
359,515
Net debt
11,112,740
11,891,689
Cash flow
Cash from operating activities
508,534
285,829
CAPEX
Cash from investing activities
(358,384)
Cash from financing activities
252,492
1,179,870
FCF
2,772,853
175,199
Balance
Cash
9,148,808
7,429,083
Long term investments
3,090,870
3,024,915
Excess cash
8,233,722
7,062,548
Stockholders' equity
12,938,607
10,303,015
Invested Capital
30,848,185
27,813,640
ROIC
16.31%
12.07%
ROCE
12.82%
9.94%
EV
Common stock shares outstanding
1,723,571
1,728,185
Price
4.97
-2.17%
5.08
-0.39%
Market cap
8,566,146
-2.43%
8,779,178
-0.39%
EV
23,940,390
22,729,585
EBITDA
5,463,997
3,876,606
EV/EBITDA
4.38
5.86
Interest
1,340,086
1,123,389
Interest/NOPBT
26.70%
32.35%